The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...

Veritas In Silico Inc. (VIS) entered a joint research agreement with Mitsubishi Gas Chemical Co. Inc. to use VIS’s mRNA structural motif analyzing platform technology, called Ibvis, to develop ...